Search

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

Q
Qahtani MH - Prevalence of Genetic Risk Factors Causing Thrombophilia in Normal Population and Recurrent Abortions Patients in Saudi Arabia
Qi X - Defining the Interaction between Cleaved High Molecular Weight Kininogen (HKa) and Tropomyosin
Qihua, Fu2  - Novel Aberrant Splicings Caused by a Splice Site Mutation IVS1a+5g > a in F7 Gene
Qiu MR - A Mechanism of Impaired Platelet Response to ADP Stimulation in the CLIC1 Knockout Mice
Qiulan D - Novel Aberrant Splicings Caused by a Splice Site Mutation IVS1a+5g > a in F7 Gene
Qu B - Study on Hemostatic and Coagulate Variations During Orthotopic Liver Transplantation
Qu K - ELISA for Detecting Immune Responses to Factor VIII
Quaglia I - Homocysteine Plasma Levels and MTHFR Genotype in Patients with Retinal Vein Occlusion
Quan M - Razaxaban, a Novel Direct Factor Xa Inhibitor, Enhanced the Antithrombotic Effects of Aspirin and Clopidogrel But Not Their Bleeding Time Effects in Rabbits
  - Antithrombotic Effects of the Direct Factor Xa Inhibitor Razaxaban in Canine Models of Thrombosis
Quarentei RCA - Intraoperative Automatic Autotransfusion for Lung Transplantation
Quehenberger P - Prediction of the Risk of Recurrent Venous Thromboembolism by the Activated Partial Thromboplastin Time
  - Favourable Pregnancy Outcome in Women with a History of Venous Thromboembolism and Prophylactic Low Molecular Weight Heparin (LMWH)
  - The Association Between Tissue Factor-Exposing Microparticles and the Activation of the Coagulation System in Cancer Patients
  - No Major Impact of Prothrombotic Conditions on The Risk of Central Venous Line-Related Thrombotic Events in Children
  - Clinical Evaluation of a New Functional Test for Detection of Activated Protein C Resistance (Pefakit® APC-R Factor V Leiden) at Two Centers in Europe and the USA
  - Evaluation of the Automated Coagulation Analyzer ACL TOPTM
  - Venous Thromboembolism in Inflammatory Bowel Disease: The Pathogenetic Role of Tissue Factor Exposing Microparticles
Queizan J - Favorable Outcome in the Pregnancy behind Treatment with Heparin in Women with Mutation of Methylenetetrahydrofolate Reductase (MTHFR) Gene and Fetal Loss Previous
Quenet S - Clinical Experience with Retrievable ALN Vena Cava Filters
Quéré I - The Factor V Leiden and Prothrombin 20210G>A Mutations as Risk Factors for Miscarriage during the First Pregnancy: The Matched Case–Control ‘Big NOHA First’ Study
Querol F - Factor VIII Mutation Type in Severe and Moderate Haemophilia A, and Inhibitor Development in a Congenital Coagulopathies Unit
  - von Willebrand Disease Type 2M: Laboratory and Molecular Studies. Results in One Single Centre
Quiang B - The Effect of Coronary Distal Embolisation on Myocardial Blood Flow and Platelet Activation
Quilici J - Low Platelet Response to Clopidogrel Increased the Risk of Recurrent Atherothrombotic Events in Patients with Non-ST Acute Coronary Syndrome after Coronary Stenting
  - Circulating Endothelial Cell Count as a Diagnostic Marker for Non-ST Elevation Acute Coronary Syndromes
Quinn DM - Kinetics of Factor VIII Assays in Mild Haemophilia A: Implications for Choice of Diagnostic Assay
Quinn C - APC Anti-infective Action is Augmented by APC Activation of Protein C
Quinn-Allen MA - Identification of the Multimerin 1 Binding Region within the C1 Domain of Factor V
  - Factor Va Membrane Binding Affinity and Prothrombinase Activity are Enhanced by Incorporation of Phosphatidylethanolamine into Phosphatidylserine Containing Membranes
Quintana M - Polipectomia in a Patient with a Moderate Congenital Deficiency of Factor V
  - Surgery in Haemophilic Patients with Inhibitor
  - Current Transfusion Practices in two Autonomous Regions in Spain: Castilla La Mancha and Extremadura. Results from the Spanish Critical Care Society Hemoderivatives Working Group
Quintavalla R - Risk Factors for CVC-Associated Thrombosis in Cancer Patients: Analysis of the ETHIC Study
Quintero-Rivera F - Thrombophilia in a Healthy Population from Northwest Colombia
Quiroga T - Activated Human Platelets Synthesize Functional Tissue Factor
  - Plasma proCPU (TAFI) Concentrations and Clot Lysis Time Are Not Different in a Chilean Population of Young Healthy Individuals Subgrouped According to the Naturally Occurring 325 Thr/Ile Polymorphism
  - Circulating Platelet-Derived Microparticles in Systemic Lupus Erythematosus: Association with Increased Thrombin Generation and Procoagulant State
Quiroga T - Inherited Mucocutaneous Bleeding: Clinical Assessment, Relative Frequency of Diseases and High Prevalence of Bleeders with Normal Laboratory Tests: Prospective Study of 280 Patients and 299 Non Bleeder Controls
Quiroga T - Patients with Mucocutaneous Bleeding and Hereditary Disorders of Primary Haemostasis Have Higher Plasma proCPU Levels But a Similar Distribution of the 325 Thr/Ile Polymorphism Compared to Age and Sex Matched Healthy Controls
Quon D - Supplemental Alpha-2-Antiplasmin Prevents Plasmin-Induced Hemorrhage
Qvigstad E - Dose-Dependent And Differential Effects of Two Doses of Continuous Combined Hormone Replacement Therapy (HRT), Tibolone And Raloxifene on Markers of Coagulation Activation